[ad_1]
Al-Marsad Journal: Scientists at the American University of Georgia revealed, in a study published on the “Nature Reports” website, that an anti-gout treatment may be effective against corona and other viruses that affect the respiratory system.
Works with all respiratory viruses
Lead author of the study and researcher of vaccines and therapeutic studies, Ralph Tripp, explained that this antiviral works with all respiratory viruses they have tested, including human respiratory syncytial virus (RSV), influenza and emerging crown, which means infection and disease can be reduced by using it. According to Al Arabiya.net
He explained that the drug is a preventive method before infection with the virus and that it is also considered a treatment after exposure to the crown and influenza, as it has been proven in the laboratory to be effective in combating against human respiratory syncytial virus (RSV).
Available for 40 years
It is worth noting that the drug (Probenecid) has been available in the market for about 40 years and is also approved by the United States Food and Drug Administration (FDA). It is primarily used to treat gout and is widely available in the United States because it has few side effects.
Source link
